Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 4, 2007, Pages 1307-1312

  Aivado, Manuel ^a,b,c   Spentzos, Dimitrios ^a,b   Germing, Ulrich ^c   Alterovitz, Gil ^d   Meng, Xiao Ying ^e   Grall, Franck ^a,b   Giagounidis, Aristoteles A N ^c   Klement, Giannoula ^d   Steidl, Ulrich ^b,c   Otu, Hasan H ^b,f   Czibere, Akos ^a,b   Prall, Wolf C ^a,b   Iking Konert, Christof ^c   Shayne, Michelle ^b   Ramoni, Marco F ^d   Gattermann, Norbert ^c   Haas, Rainer ^c   Mitsiades, Constantine S ^a   Fung, Eric T ^e   Libermann, Towia A ^a,b  

^a DANA FARBER HARVARD CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CIPHERGEN BIOSYSTEMS INC   (United States)

^f YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Biomarker; Chemokine; Hematologic malignancy; Proteomics

Indexed keywords

ALPHA CHEMOKINE; BIOLOGICAL MARKER; CXC CHEMOKINE LIGAND 4; CXC CHEMOKINE LIGAND 7; PROTEOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; FEMALE; GENETIC TRANSCRIPTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEOMICS; RNA TRANSLATION; VALIDATION PROCESS; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CHEMOKINES, CXC; HUMANS; MASS SPECTROMETRY; MYELODYSPLASTIC SYNDROMES; PROTEOME;

EID: 33846613303     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0610330104     Document Type: Article

References (52)

1. Aul C, Gattermann N, Schneider W (1992) Br J Haematol 82:358-367.
2. Williamson PJ, Kruger AR, Reynolds PJ, Hamblin TJ, Oscier DG (1994) Br J Haematol 87:743-745.
3. Germing U, Gattermann N, Strupp C, Aivado M, Aul C (2000) Leukemia Res 24:983-992.
4. Ramos F, Fernandez-Ferrero S, Suarez D, Barbon M, Rodriguez JA, Gil S, Megido M, Ciudad J, Lopez N, del Canizo C, Orfao A (1999) Leukemia Res 23:283-290.
5. Heaney ML, Golde DW (1999) N Engl J Med 340:1649-1660.
6. Steensma DP, Tefferi A (2003) Leukemia Res 27:95-120.
7. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, et al. (1997) Blood 89:2079-2088.
8. Lubbert M, Jonas D, Miller CW, Herrmann F, Mertelsmann R, McCormick F, Koeffler HP (1990) Oncogene 5:583-587.
9. Ruter B, Wijermans PW, Lubbert M (2004) Int J Hematol 80:128-135.
10. Westwood NB, Mufti GJ (2003) Curr Hematol Rep 2:186-192.
11. Meyers CA, Albitar M, Estey E (2005) Cancer 104:788-793.
12. Hsu HC, Lee YM, Tsai WH, Jiang ML, Ho CH, Ho CK, Wang SY (2002) Oncology 63:64-69.
13. Alexandrakis MG, Passam FH, Pappa CA, Damilakis J, Tsirakis G, Kandidaki E, Passam AM, Stathopoulos EN, Kyriakou DS (2005) Int J Immunopathol Pharmacol 18:287-295.
14. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, et al. (2002) Science 298:995-1000.
15. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL, Jr (2002) Cancer Res 62:3609-3614.
16. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, Reddy ST, Farias-Eisner R (2003) Proc Natl Acad Sci USA 100:12343-12348.
17. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA (2002) Lancet 359:572-577.
18. Aivado M, Spentzos D, Alterovitz G, Otu HH, Grall F, Giagounidis AA, Wells M, Cho JY, Germing U, Czibere A, et al. (2005) Clin Chem Lab Med 43:133-140.
19. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, et al. (2005) Clin Chem 51:102-112.
20. Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) J Natl Cancer Inst 93:1054-1061.
21. Zhu W, Wang X, Ma Y, Rao M, Glimm J, Kovach JS (2003) Proc Natl Acad Sci USA 100:14666-14671.
22. Simon R, Radmacher MD, Dobbin K, McShane LM (2003) J Natl Cancer Inst 95:14-18.
23. Ransohoff DF (2004) Nat Rev Cancer 4:309-314.
24. Zhang Z, Bast RC, Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, et al. (2004) Cancer Res 64:5882-5890.
25. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. (2002) Nature 415:530-536.
26. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al. (2002) N Engl J Med 347:1999-2009.
27. Rosenthal NS, Farhi DC (1996) Am J Clin Pathol 106:676-679.
28. Knipp S, Hildebrandt B, Richter J, Haas R, Germing U, Gattermann N (2005) Haematologica 90:691-693.
29. List AF, Vardiman J, Issa JP, DeWitte TM (2004) Hematology (Am Soc Hematol Educ Program), 297-317.
30. Walz A, Baggiolini M (1990) J Exp Med 171:449-454.
31. Petersen F, Ludwig A, Flad HD, Brandt E (1996) J Immunol 156:1954-1962.
32. Ruutu P, Ruutu T, Vuopie P, Kosunen TU, de la Chapelle A (1977) Nature 265:146-147.
33. Greenberg PL (1983) Blood 61:1035-1044.
34. Dudek AZ, Nesmelova I, Mayo K, Verfaillie CM, Pitchford S, Slungaard A (2003) Blood 101:4687-4694.
35. Han ZC, Lu M, Li J, Defard M, Boval B, Schlegel N, Caen JP (1997) Blood 89:2328-2335.
36. Gewirtz AM, Zhang J, Ratajczak J, Ratajczak M, Park KS, Li C, Yan Z, Poncz M (1995) Blood 86:2559-2567.
37. Vinci G, Tabilio A, Deschamps JF, Van Haeke D, Henri A, Guichard J, Tetteroo P, Lansdorp PM, Hercend T, Vainchenker W, et al. (1984) Br J Haematol 56, 589-605.
38. Pamphilon DH, Aparicio SR, Roberts BE, Menys VC, Tate G, Davies JA (1984) Scand J Haematol 33:486-491.
39. Blockmans D, Heynen MJ, Verhoef GE, Vermylen J (1995) Haematologia (Budapest) 26:159-172.
40. Zeidman A, Sokolover N, Fradin Z, Cohen A, Redlich O, Mittelman M (2004) Hematol J 5:234-238.
41. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Br J Haematol 51:189-199.
42. Bennett JM (2000) Int J Hematol 72:131-133.
43. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) Arthritis Rheum 25:1271-1277.
44. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, Lee CC, Leung TW, Ho SK, Johnson PJ (2003) Clin Chem 49:752-760.
45. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Clin Chem 48:1296-1304.
46. Lichtenthaler SF, Beher D, Grimm HS, Wang R, Shearman MS, Masters CL, Beyreuther K (2002) Proc Natl Acad Sci USA 99:1365-1370.
47. Califano A (2000) Bioinformatics 16:341-357.
48. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, et al. (2001) J Exp Med 194:1625-1638.
49. Lepre J, Rice JJ, Tu Y, Stolovitzky G (2004) Bioinformatics 20:1033-1044.
50. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA, Cannistra SA (2004) J Clin Oncol 22:4648-4658.
51. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, et al. (1999) Science 286:531-537.
52. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ (2002) Nat Genet 30:41-47.